Results 1 to 10 of about 16,946 (180)
Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey. [PDF]
Health Sci Rep, 2023 Abstract Background and Aims Involving patients in research, not only as trial subjects, is not a newly established practice. Over the last two decades, patient roles have gradually expanded to become active research contributors, creating a more patient‐centered research landscape.
Nohová I +5 more
europepmc +2 more sources
Descripción de los síntomas de alarma en las mujeres con cáncer ginecológico [PDF]
Atención PrimariaResumen: Objetivo: Describir la forma de presentación del cáncer ginecológico en atención primaria, cuantificando la presencia de síntomas de alarma, y estableciendo su relación con el intervalo de tiempo hasta el diagnóstico y el tratamiento.
Blanca Sánchez-Galindo +5 more
doaj +2 more sources
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 [PDF]
Repertorio de Medicina y Cirugía, 2016 El cáncer de ovario presenta alta prevalencia con 238.719 casos reportados a nivel mundial, cuya mortalidad alcanza y supera el 50%, siendo la mayor causada por cáncer ginecológico.
Edmundo Mora Padilla +1 more
doaj +3 more sources
Gaceta Mexicana de Oncolog�a, 2023 Dos mujeres mexicanas previamente sanas de 18 años, referidas a valoración médica por presencia de ascitis. Los estudios de imagen revelaron la presencia de tumoraciones dependientes de ovario, así como elevación de CA-125, por lo que se realizó laparotomía diagnóstica con reporte de patología de un adenocarcinoma seroso papilar de alto grado.
Patricia Cortés-Esteban +4 more
openaire +2 more sources
Cells, 2021 Non-coding RNAs are emergent elements from the genome, which do not encode for proteins but have relevant cellular functions impacting almost all the physiological processes occurring in eukaryotic cells. In particular, microRNAs and long non-coding RNAs
César López-Camarillo +6 more
doaj +1 more source
Cancer, Volume 129, Issue 12, Page 1846-1855, 15 June 2023., 2023 Abstract Background The PRIMA/ENGOT‐OV26/GOG‐3012 (NCT02655016) trial was amended to prospectively evaluate the safety and efficacy of an individualized starting dose (ISD) regimen of niraparib for first‐line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Mansoor R. Mirza +20 more
wiley +1 more source
Top advances of the year: Cervical cancer
Cancer, Volume 129, Issue 5, Page 657-663, 1 March 2023., 2023 Abstract Cervical cancer continues to affect women in the United States and throughout the world despite an effective vaccine against human papillomavirus and cancer screening programs. For the women who develop cervical cancer, surgery, radiation, and chemotherapy have been the mainstays of treatment for years.
Sarah E. Podwika, Linda R. Duska
wiley +1 more source
Immunotherapies in ovarian cancer
EJC Supplements, 2020 Ovarian cancer is the leading cause of death for gynaecological cancer, and new therapies are urgently awaited. Although the presence of tumour-infiltrating lymphocytes has been confirmed to be associated to a better prognosis, immunotherapy is not yet ...
Elena García-Martínez +1 more
doaj +1 more source
Sinonasal inverted papilloma – malignant transformation and non‐sinonasal malignancies
The Laryngoscope, Volume 133, Issue 3, Page 506-511, March 2023., 2023 Objectives To assess malignant transformation rate, non‐sinonasal malignancies, and factors contributing to recurrence in patients treated for sinonasal inverted papilloma (SNIP). Study Design Retrospective study. Methods We retrospectively reviewed medical records of all patients treated for SNIP (n = 296) between the years 1984–2014 at Helsinki ...
Sanna Viitasalo +10 more
wiley +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 61, Issue 2, Page 231-242, February 2023., 2023 ABSTRACT Objective Previous work has suggested that the ultrasound‐based benign simple descriptors (BDs) can reliably exclude malignancy in a large proportion of women presenting with an adnexal mass. This study aimed to validate a modified version of the BDs and to validate a two‐step strategy to estimate the risk of malignancy, in which the modified ...
C. Landolfo +30 more
wiley +1 more source